BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nezu S, Tanaka A, Yasui H, Imamura M, Nakajima H, Ishida H, Takahashi S. Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis. J Gastroenterol Hepatol 2006;0:060606032707024-???. [DOI: 10.1111/j.1440-1746.2006.04434.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 21] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Czaja AJ, Bayraktar Y. Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment. World J Gastroenterol 2009; 15(19): 2314-2328 [PMID: 19452572 DOI: 10.3748/wjg.15.2314] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
2 Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology. 2019;69:394-419. [PMID: 30070375 DOI: 10.1002/hep.30145] [Cited by in Crossref: 86] [Cited by in F6Publishing: 92] [Article Influence: 21.5] [Reference Citation Analysis]
3 Liaskos C, Bogdanos DP, Rigopoulou EI, Dalekos GN. Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact? J Gastroenterol Hepatol. 2007;22:454-455. [PMID: 17295788 DOI: 10.1111/j.1440-1746.2006.04751.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
4 Tan S, Ayutyanont N, Bhattarai B, Movahedi Z, Jayaram L, Gish R, Nadir A. Clinical characteristics of antimitochondrial antibody-positive patients at a safety net health care system in Arizona. BMJ Open Gastroenterol. 2017;4:e000158. [PMID: 29018539 DOI: 10.1136/bmjgast-2017-000158] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
5 Gatselis NK, Zachou K, Koukoulis GK, Dalekos GN. Autoimmune hepatitis, one disease with many faces: Etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol 2015; 21(1): 60-83 [PMID: 25574080 DOI: 10.3748/wjg.v21.i1.60] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 66] [Article Influence: 10.4] [Reference Citation Analysis]
6 Dhiman P, Malhotra S. Overlap syndromes: an emerging diagnostic and therapeutic challenge. Saudi J Gastroenterol 2014;20:342-9. [PMID: 25434314 DOI: 10.4103/1319-3767.145316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Alfano AM, Romito A, Marchese C, Battistini M, Crotti G, Ferrini A, Mancinetti C, Manetta T, Mengozzi G, Merlach P, Migliardi M, Tambuzzo MT. Diagnostic accuracy of two tests for determination of anti-m2 in the diagnosis of primary biliary cirrhosis: Is it possible to predict the course of the disease? Immunol Res 2017;65:299-306. [PMID: 27475095 DOI: 10.1007/s12026-016-8838-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Talukdar A, Khanra D, Mukherjee K, Saha M. Autoimmune hepatitis in a teenage boy: 'overlap' or 'outlier' syndrome--dilemma for internists. BMJ Case Rep. 2013;2013. [PMID: 23396934 DOI: 10.1136/bcr-2012-008335] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Seike T, Komura T, Shimizu Y, Omura H, Kumai T, Kagaya T, Ohta H, Kawashima A, Harada K, Kaneko S, Unoura M. A Young Man with Non-alcoholic Steatohepatitis and Serum Anti-mitochondrial Antibody Positivity. Intern Med 2018;57:3093-7. [PMID: 29877264 DOI: 10.2169/internalmedicine.0405-17] [Reference Citation Analysis]
10 Tan S, Movahedi Z, Beisel J, Ayutyanont N, Nadir A. Correlation of Anti-mitochondrial Antibodies with Liver Histology and Outcomes. Dig Dis Sci 2016;61:1770-1. [PMID: 26972083 DOI: 10.1007/s10620-016-4094-5] [Reference Citation Analysis]
11 Chascsa DMH, Lindor KD. Emerging therapies for PBC. J Gastroenterol 2020;55:261-72. [PMID: 31970467 DOI: 10.1007/s00535-020-01664-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Patel I, Ching Companioni R, Bansal R, Vyas N, Catalano C, Aron J, Walfish A. Acute hepatitis E presenting with clinical feature of autoimmune hepatitis. J Community Hosp Intern Med Perspect. 2016;6:33342. [PMID: 27987286 DOI: 10.3402/jchimp.v6.33342] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
13 Czaja AJ. The overlap syndromes of autoimmune hepatitis. Dig Dis Sci. 2013;58:326-343. [PMID: 22918690 DOI: 10.1007/s10620-012-2367-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 23] [Article Influence: 0.3] [Reference Citation Analysis]
14 Dalekos GN, Koskinas J, Papatheodoridis GV. Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis. Ann Gastroenterol 2019;32:1-23. [PMID: 30598587 DOI: 10.20524/aog.2018.0330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
15 Czaja AJ. Difficult treatment decisions in autoimmune hepatitis. World J Gastroenterol 2010; 16(8): 934-947 [PMID: 20180231 DOI: 10.3748/wjg.v16.i8.934] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
16 Gabeta S, Norman GL, Liaskos C, Papamichalis PA, Zografos T, Garagounis A, Rigopoulou EI, Dalekos GN. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol 2007;27:378-87. [PMID: 17514501 DOI: 10.1007/s10875-007-9092-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
17 Abdollahi MR, Somi MH, Faraji E. Role of international criteria in the diagnosis of autoimmune hepatitis. World J Gastroenterol 2013; 19(23): 3629-3633 [PMID: 23801865 DOI: 10.3748/wjg.v19.i23.3629] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
18 Hu C, Deng C, Song G, Zhang W, Zhang S, Li X, Li P, Zhang F, Li Y. Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis. Dig Dis Sci. 2011;56:3357-3363. [PMID: 21660486 DOI: 10.1007/s10620-011-1756-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
19 Czaja AJ. Autoantibody-negative autoimmune hepatitis. Dig Dis Sci. 2012;57:610-624. [PMID: 22187100 DOI: 10.1007/s10620-011-2017-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
20 Rizvi S, Gawrieh S. Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management. Drugs Aging. 2018;35:589-602. [PMID: 29971609 DOI: 10.1007/s40266-018-0556-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
21 Czaja AJ. Performance parameters of the conventional serological markers for autoimmune hepatitis. Dig Dis Sci. 2011;56:545-554. [PMID: 21127976 DOI: 10.1007/s10620-010-1501-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
22 Himoto T, Nishioka M. Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. Auto Immun Highlights. 2013;4:39-53. [PMID: 26000142 DOI: 10.1007/s13317-013-0046-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]